Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Report 2025

The quantitative polymerase chain reaction (qPCR) instruments market size has grown rapidly in recent years. It will grow from $1.51 billion in 2024 to $1.66 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth during the historic period can be attributed to the increasing burden of chronic diseases, expanding applications in genetic and genomic research, rising public and private investments in life sciences, growing popularity of point-of-care diagnostics, and heightened demand for high-throughput testing systems.

The quantitative polymerase chain reaction (qPCR) instruments market size is expected to see rapid growth in the next few years. It will grow to $2.45 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth during the forecast period can be attributed to the increasing prevalence of infectious diseases, rising demand for personalized medicine, expanding use of qPCR in oncology, growing adoption of qPCR in clinical laboratories, and heightened focus on early disease detection. Major trends in the forecast period include technological advancements in qPCR platforms, integration of automation technologies, progress in microfluidics, development of multiplex qPCR technologies, and incorporation of cloud-based data management systems.

The rising incidence of infectious diseases is expected to drive the growth of the quantitative polymerase chain reaction (qPCR) instruments market in the future. Infectious diseases are caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly between individuals. The increase in infectious diseases is largely due to the growth in global travel, which accelerates the spread of pathogens across borders. Quantitative polymerase chain reaction (qPCR) instruments assist in combating infectious diseases by providing rapid, sensitive, and precise detection of pathogens, enabling timely diagnosis and effective management of diseases. For example, in February 2024, GOV.UK, a UK government department, reported that tuberculosis (TB) cases in England rose from 4,380 in 2022 to 4,850 in 2023. Hence, the growing incidence of infectious diseases is propelling the expansion of the qPCR instruments market.

Key players in the quantitative polymerase chain reaction (qPCR) instruments market are focusing on developing advanced technologies, such as next-generation qPCR platforms, to improve testing accuracy, enhance workflow efficiency, and strengthen their competitive position in diagnostics. Next-generation qPCR platforms are advanced molecular diagnostic systems designed to offer greater sensitivity, faster processing, expanded multiplexing capabilities, and increased automation for superior testing performance and precision. For instance, Roche Holding AG, a Switzerland-based pharmaceutical company, introduced the LightCycler PRO System, which provides next-generation qPCR functionalities with enhanced speed, accuracy, and automation. It delivers reliable, flexible, and efficient real-time PCR results for clinical and research applications and features advanced multiplexing, user-friendly software, and precise temperature control for consistent outcomes. Its advantages include quick adaptation to changing testing needs, optimized workflows with simplified data handling, and an improved user interface featuring a large touchscreen and seamless system integration.

In April 2023, Thermo Fisher Scientific Inc., a US-based life sciences and clinical research company, formed a partnership with ALPCO-GeneProof to broaden access to PCR diagnostic solutions. Through this collaboration, Thermo Fisher aims to expand its molecular diagnostics portfolio by increasing its CE-IVD assay offerings and strengthening its presence in the European clinical testing market. ALPCO-GeneProof is a US-based diagnostics firm specializing in both molecular and immunodiagnostic solutions.

Major players in the quantitative polymerase chain reaction (qpcr) instruments market are F. Hoffmann-La Roche AG., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf SE, Cepheid Inc., Takara Bio Inc., bioMérieux SA, Analytik Jena GmbH, Standard BioTools Inc., Hangzhou Bioer Technology Co. Ltd., BioTeke Corporation, GeneReach Biotechnology Corp., Anitoa Systems LLC, Blue-Ray Biotech Corp., Chai Biotechnologies, Bio Molecular Systems Pty Ltd., Azure Biosystems Inc.

North America was the largest region in the quantitative polymerase chain reaction (qPCR) instruments market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in quantitative polymerase chain reaction (qPCR) instruments report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the quantitative polymerase chain reaction (qPCR) instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quantitative polymerase chain reaction (qPCR) instrument market consists of revenues earned by entities providing services such as analysis software, installation and training, technical support, and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The quantitative polymerase chain reaction (qPCR) instrument market also includes sales of thermal cyclers, optical detection systems, reaction tubes and plates, and analysis software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The quantitative polymerase chain reaction (qPCR) instruments market research report is one of a series of new reports that provides quantitative polymerase chain reaction (qPCR) instruments market statistics, including the quantitative polymerase chain reaction (qPCR) instruments industry's global market size, regional shares, competitors with the quantitative polymerase chain reaction (qPCR) instruments market share, detailed quantitative polymerase chain reaction (qPCR) instruments market segments, market trends and opportunities, and any further data you may need to thrive in the quantitative polymerase chain reaction (qPCR) instruments market. This quantitative polymerase chain reaction (qPCR) instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Quantitative polymerase chain reaction (qPCR) instruments are specialized laboratory devices used to amplify and simultaneously quantify specific DNA sequences in real time. These instruments track DNA accumulation during each amplification cycle through fluorescent signals, enabling researchers to measure DNA amounts with high sensitivity and precision. They are vital tools in molecular biology, diagnostics, and research for applications including gene expression analysis, pathogen detection, and genetic variation studies.

The main product types of quantitative polymerase chain reaction (qPCR) instruments include quantitative polymerase chain reaction systems, reagents and consumables, and software. Quantitative polymerase chain reaction systems are laboratory instruments designed to amplify and quantify DNA or RNA sequences in real time using fluorescence-based detection. These systems include models such as the 7500, ViiA 7 Dx, Cobas 4800, CFX96, SmartCycler, GeneXpert, Rotor-Gene Q, Rotor-Gene Q 5plex HRM System, BioFire FilmArray systems, and others. They are applied in various fields like gene expression analysis, genotyping, pathogen detection, and diagnostics, and are utilized by end users including diagnostic laboratories, hospitals and clinics, pharmaceutical and biotechnology companies, among others.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.